Dec 3 (Reuters) - Arix Bioscience PLC ARIX.L :
* REG-ARIX BIOSCIENCE PLC ARTIOS AND MERCK KGAA ANNOUNCE
GLOBAL
STRATEGIC COLLABORATION
* ARIX BIOSCIENCE - TO RECEIVE $30 MILLION IN UPFRONT,
NEAR-TERM
PAYMENTS, PLUS DOUBLE DIGIT OPTION FEES AND UP TO US$860 MILLION
IN TOTAL MILESTONES PER TARGET
* ARIX BIOSCIENCE PLC - MERCK KGAA SHALL HAVE RIGHT TO OPT
INTO
EXCLUSIVE DEVELOPMENT AND COMMERCIALISATION OF COMPOUNDS ON UP
TO EIGHT TARGETS
* ARIX BIOSCIENCE PLC - THREE-YEAR STRATEGIC RESEARCH
COLLABORATION TO DISCOVER AND DEVELOP MULTIPLE PRECISION
ONCOLOGY DRUGS
Source text for Eikon: ID:nEQ5VwXHLa
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))